New government grant to protect our patents

The National Agency for Research and Inno­va­tion (ANII) of Uruguay has granted Xeptiva Ther­a­peu­tics new funding to cover the costs asso­ci­ated with the national patent phases of its prod­ucts in Latin America, Asia and Europe. This request was approved by ANII in June 2024.

The project, titled “Support for Patent Reg­is­tra­tion of Inven­tions and Utility Models”, includes six ini­tia­tives that meet this objec­tive and seek to strengthen the company’s intel­lec­tual prop­erty pro­tec­tion in key markets.

These patent phases are essen­tial to ensure that Xeptiva’s devel­op­ments are pro­tected in various regions, allow­ing the company to max­i­mize its com­mer­cial poten­tial and expand its inter­na­tional pres­ence.

The funding pro­vided by ANII covers 80% of the total costs asso­ci­ated with these projects, while the remain­ing 20% will be con­trib­uted by Xeptiva. The dura­tion of each project is 12 months.

This gov­ern­ment grant rep­re­sents an essen­tial pillar for Xeptiva, as it will facil­i­tate the acqui­si­tion of patents in strate­gic markets, which in turn will enhance its research and devel­op­ment capa­bil­i­ties.